-
Seres Therapeutics Reports Second Quarter Financial Results and Provides Progress Update
Post on 8/6/19
-
Kala Pharmaceuticals Reports Second Quarter 2019 Financial Results
Post on 8/6/19
-
Neon Therapeutics Reports Second Quarter 2019 Financial Results
Post on 8/6/19
-
Karyopharm Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress
Post on 8/6/19
-
CVS Pharmacy Expands CarePass Program Nationwide
Post on 8/5/19
-
Arvinas Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Post on 8/5/19
-
2019’s Best & Worst States for Health Care – WalletHub Study
Post on 8/5/19
-
Bristol-Myers Looks Incredibly Cheap
Post on 8/5/19
-
3 Things You Can Expect With CVS Health's Q2 Earnings Update
Post on 8/5/19
-
IDEXX Labs Fetches Double-Digit Profit Growth
Post on 8/5/19
-
Exicure Closes its Offering of Common Stock
Post on 8/4/19
-
Ironwood Pharmaceuticals' Blowout Q2 Results: What You'll Want to Know
Post on 8/1/19
-
Translate Bio Announces Second Quarter 2019 Financial Results and Provides Corporate Update
Post on 7/31/19
-
Shields Health Solutions Receives Equity Investments From Welsh, Carson, Anderson & Stowe and Walgreen
Post on 7/31/19
-
Flexion Therapeutics: The Time To Buy Is Now
Post on 7/31/19
-
Biogen Hedged Its Bet and Won Big
Post on 7/31/19
-
Exicure Proposes Public Offering of Common Stock
Post on 7/30/19
-
Infinity Pharmaceuticals Provides Company Update
Post on 7/30/19
-
PROMETRIKA Partners with Comprehend
Post on 7/30/19
-
Cognex Corporation (CGNX) CEO Robert Willett on Q2 2019 Results - Earnings Call Transcript
Post on 7/30/19
-
Berkshire Hathaway: If You Can't Value It, Don't Buy It
Post on 7/30/19
-
Better Buy: Rite Aid vs. CVS Health
Post on 7/30/19
-
Cambridge BioMarketing Recognized with Recent Awards
Post on 8/7/19
-
Cara Therapeutics Closes Public Offering of Common Stock
Post on 7/29/19
-
Innovation Pharmaceuticals Provides Corporate Update
Post on 7/29/19